Bailard, Inc. Vertex Pharmaceuticals Inc Transaction History

Bailard, Inc.

$3.84 Billion
Q4 2024

A detailed history of Bailard, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bailard, Inc. holds 37,415 shares of VRTX stock, worth $19.1 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

37,415

Previous 38,517 2.86%

Holding current value

$19.1 Million

Previous $17.9 Million 15.89%

% of portfolio

0.39%

Previous 0.47%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$396.64 - $516.74 $437,097 - $569,447	-1,102 Reduced 2.86%	37,415 $15.1 Million
Q3 2024 Oct 30, 2024	BUY	$460.0 - $505.78 $17,020 - $18,713	37 Added 0.1%	38,517 $17.9 Million
Q2 2024 Jul 25, 2024	SELL	$392.81 - $485.53 $102,130 - $126,237	-260 Reduced 0.67%	38,480 $18 Million
Q1 2024 May 08, 2024	BUY	$407.69 - $446.08 $167,152 - $182,892	410 Added 1.07%	38,740 $16.2 Million
Q4 2023 Feb 02, 2024	BUY	$343.0 - $410.68 $311,444 - $372,897	908 Added 2.43%	38,330 $15.6 Million
Q3 2023 Oct 24, 2023	BUY	$338.18 - $362.46 $354,074 - $379,495	1,047 Added 2.88%	37,422 $13 Million
Q2 2023 Jul 20, 2023	BUY	$314.42 - $351.91 $116,964 - $130,910	372 Added 1.03%	36,375 $12.8 Million
Q1 2023 May 08, 2023	BUY	$283.23 - $323.1 $6.56 Million - $7.48 Million	23,165 Added 180.44%	36,003 $11.3 Million
Q4 2022 Feb 02, 2023	BUY	$285.76 - $321.48 $2.92 Million - $3.28 Million	10,201 Added 386.84%	12,838 $3.71 Million
Q3 2022 Oct 18, 2022	BUY	$273.83 - $305.53 $722,089 - $805,682	2,637 New	2,637 $764,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $298,296 - $351,770	-1,591 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $124,212 - $144,786	-600 Reduced 27.38%	1,591 $342,000
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $12,213 - $16,289	59 Added 2.77%	2,191 $518,000
Q3 2020 Nov 10, 2020	SELL	$255.65 - $303.1 $17,895 - $21,217	-70 Reduced 3.18%	2,132 $580,000
Q1 2020 Apr 16, 2020	BUY	$199.77 - $247.81 $399 - $495	2 Added 0.09%	2,202 $524,000
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $178,464 - $202,215	-1,300 Reduced 37.14%	2,200 $0
Q4 2015 Jan 29, 2018	BUY	N/A	3,500	3,500 $0

Others Institutions Holding VRTX

# of Institutions

1,764

Shares Held

222M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $131B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account